Business
COVID-19 vaccine from Johnson & Johnson may be gamechanger – NEWS.com.au
COVID-19 vaccine from Johnson & Johnson may be gamechanger
As the a global COVID-19 vaccine standoff continues, theres a new player in town and this jabs unique quality could be a gamechanger for the rollout.Johnson & Johnson’s product has an overall efficacy of at least 66 per cent, the company announced on Friday, and crucially, the vaccine only requires one dose.
This sets it apart from the other jabs that have been approved in western countries so far from Pfizer/BioNTech, Moderna and Oxford/AstraZeneca. These vaccines all require two shots, given several…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Business20 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
General24 hours agoFederal politics live: Government says RBA rate cut decision about ‘pace, not direction’
-
General24 hours agoReserve Bank board still looking for yesterday’s news